COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 285: Articles 2841-2850  | Next

Inverse folding of protein complexes with a structure-informed language model enables unsupervised antibody evolution
Shanker, V. R., Bruun, T. U. J., Hie, B. L., Kim, P. S.
10.1101/2023.12.19.572475 — Posted: 2023-12-20
Predicting the Trend of SARS-CoV-2 Mutation Frequencies Using Historical Data
zhou, x., Hu, K., Pan, M., Zhang, C., Cao, S.
10.1101/2023.12.19.572480 — Posted: 2023-12-20
Clinical, laboratory, and imaging findings of stage 3-5 chronic kidney disease patients suffering from COVID-19 in Bangladesh: a prospective cross-sectional study
Ullah, A., Khanam, A., Mondal, M., Haque, M. R., Sumon, A. S. H., Khan, S., Haque, M. M., Sumon, M. R., Rahman, M. M.
10.1101/2023.12.18.23300150 — Posted: 2023-12-19
The magnitude and cross reactivity of SARS-CoV-2 specific antibody responses in vaccinated and unvaccinated Sri Lankan children and association with nutrition status
Jeewandara, C., Karunananda, M. V., Fernando, S., Danasekara, S., Jayakody, G., Arulkumaran, S., Samaraweera, N. Y., Kumarawansha, S., Sivaganesh, S., Amarasinghe, P. G., Jayasinghe, C., Wijesekara, D., Marasinghe, M. B., Mambulage, U., Wijayatilaka, H., Seneviratne, K., Bandara, A. D. P., Gallage, C. P., Colambage, N. R., Udayasiri, T. T., Lokumarambage, T., Upasena, Y., Weerasooriya, W. P. K. P., Seroprevalence Study Group, , Tang, T. K., Townsend, A., Ogg, G. S., Malavige, G. N.
10.1101/2023.12.18.23300176 — Posted: 2023-12-19
Covid-19 Risk by work-related factors: Pooled analysis of individual linked data from 14 cohorts
Gittins, M., Rhodes, S., Wels, J., Wielgoszewska, B., Zhu, J., Shaw, R. J., Hamilton, O. K., Demou, E., Stevenson, A. J., Rhead, R., Katikireddi, S. V., Ploubidis, G. B., van Tongeren, M.
10.1101/2023.12.19.23298502 — Posted: 2023-12-19
Leveraging informative missing data to learn about acute respiratory distress syndrome and mortality in long-term hospitalized COVID-19 patients throughout the years of the pandemic
Getzen, E. J., Tan, A. L., Brat, G., Omenn, G. S., Strasser, Z., The Consortium for Clinical Characterization of COVID-19 by EHR (4CE), , Long, Q., Holmes, J. H., Mowery, D.
10.1101/2023.12.18.23300181 — Posted: 2023-12-19
Tracking COVID-19 in England and Wales: Insights from Virus Watch - a prospective community cohort study
Fong, W. L. E., Nguyen, V. G., Beale, S., Byrne, T. E., Geismar, C., Fragaszy, E., Kovar, J., Navaratnam, A. M. D., Yavlinsky, A., Abubakar, I., Hayward, A. C., Aldridge, R. W.
10.1101/2023.12.19.23299951 — Posted: 2023-12-19
Estimating social contact rates for the COVID-19 pandemic using Google mobility and pre-pandemic contact surveys
Prestige, E., Coletti, P., Backer, J. A., Davies, N. J., Edmunds, W. J., Jarvis, C. I.
10.1101/2023.12.19.23300209 — Posted: 2023-12-19
Interferon signaling in the nasal epithelium distinguishes among lethal and common cold respiratory viruses and is critical for viral clearance
Otter, C. J., Renner, D. M., Fausto, A., Tan, L. H., Cohen, N. A., Weiss, S. R.
10.1101/2023.12.18.571720 — Posted: 2023-12-19
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera
Roessler, A., Netzl, A., Knabl, L., Wilks, S. H., Muehlemann, B., Tuereli, S., Mykytyn, A., von Laer, D., Haagmans, B. L., Smith, D. J., Kimpel, J.
10.1101/2023.12.19.572347 — Posted: 2023-12-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).